Exoantigens of Aspergillus Fumigatus: Serodiagnosis and Virulence

  • J. P. Latgé
  • S. Paris
  • J. Sarfati
  • J. P. Debeaupuis
  • M. Monod
Part of the Federation of European Microbiological Societies Symposium Series book series (FEMS, volume 69)

Abstract

Aspergillus fumigatus commonly grows in damp environments such as soil, decaying vegetation and organic debris from which it releases a high number of spores into the atmosphere (Raper and Fennell, 1965). The number of A. fumigatus conidia present in the air usually varies from 0.1 to 10 spores/m3, but may reach 106/m3 under certain environmental conditions (Mullins et al., 1976; Bodey and Vartivarian, 1989; Gumowski et al., 1992). Due to their small size (2–3 μm) and presence in the air, A. fumigatus conidia are inhaled by all individuals and transit through the upper respiratory tract, bronchia and bronchiola to end in the alveoli (Cole and Samson, 1984). The pulmonary epithelium is the largest epithelial surface exposed to the external environment (40–80 m2/individual). It possesses several lines of defence capable of expelling A. fumigatus from the lung (Seaton et al., 1989). Impairment of these defence mechanisms can lead to the establishment of the fungus in the lung. This impairment can be of genetical (cystic fibrosis, chronic granulomatous disease) or clinical origin (tuberculosis, chemo- and corticotherapy) (Cohen et al., 1981; Wagner, 1984; Schönheyder et al, 1988; Bodey and Vartivarian, 1989; Cohen, 1991). There are three clinical manifestations of A. fumigatus infections: 1) allergie bronchopulmonary aspergillosis (ABPA) resulting from repeated inhalation of conidia with limited fungal growth; 2) aspergilloma where colonisation of a pre-existing pulmonary cavity forms a fungal ball; 3) invasive pulmonary aspergillosis where A. fumigatus invades lung parenchyma and disseminates to other organs.

Keywords

Surfactant Tuberculosis Polysaccharide Histidine Oligosaccharide 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Arruda L.K., Mann B.J., and Chapman M.D. (1992) Selective expression of a major allergen and cytotoxin, Asp fI, in Aspergillus fumigatus. Implications for the immunopathogenesis of Aspergillus-related diseases. J. Immunol. 149, 3354–3359.PubMedGoogle Scholar
  2. Arruda L.K., Platts-Mills T.A., Fox J.W., and Chapman M.D. (1990) Aspergillus fumigatus allergen I, a major IgE-binding protein, is a member of the mitogillin family of cytotoxins. J. Exp. Med. 172, 1529–1532.PubMedCrossRefGoogle Scholar
  3. Azuma I., Kimura H., Hirao F., Tsubura E., Yamamura Y., and Misaki A. (1971) Biochemical and immunological studies on Aspergillus. III: chemical and immunological properties of glycopeptide obtained from Aspergillus fumigatus. Jpn J. Microbiol. 15, 237–246.Google Scholar
  4. Barreto-Bergter E., Gorin P.A.J., and Travassos L.R. (1981) Cell constituents of mycelia and conidia of Aspergillus fumigatus. Carbohydr. Res. 95, 205–218.CrossRefGoogle Scholar
  5. Bennett J.E., Bhattacharjee A.K., and Glaudemans C.P.J. (1985) Galactofuranosyl groups are immunodominant in Aspergillus fumigatus galactomannan. Mol. Immunol. 22, 251–254.PubMedCrossRefGoogle Scholar
  6. Bernstein J.A., Zeiss C.R., Greenberger P.A., Patterson R., Marhoul J.F., Smith L.L., (1990), Immunoblot analysis of sera from patients with allergic bronchopulmonary aspergillosis: correlation with disease activity. J Allergy Clin. Immunol. 86, 532–539.PubMedCrossRefGoogle Scholar
  7. Biguet J., Tran van Ky P., Andrieu S., and Fruit J. (1964) Analyse immunoélectrophorétique d’extraits cellulaires et de milieux de culture d’Aspergillus fumigatus par des immunsérums expérimentaux et des sérums de malades atteints d’aspergillome bronchopulmonaire, Ann. Inst. Past. 107, 73–97.Google Scholar
  8. Bodey G.P., and Vartivarian S. (1989) Aspergillosis. Eur. J. Clin. Microbiol. Infect. Dis. 8, 413–437.PubMedCrossRefGoogle Scholar
  9. Borglum-Jensen T.D., Schoenheyder H., Andersen P., and Stenderup A. (1986) Binding of C-reactive protein to Aspergillus fumigatus fractions. J. Med. Microbiol. 21, 173–177.CrossRefGoogle Scholar
  10. Bouziane H., Latgé J.P., Prévost M.C., Chevance L.G., and Paris S. (1988) Nasal allergy in guinea pigs. Mycopathologia 101, 181–186.PubMedCrossRefGoogle Scholar
  11. Brandhorst T.T., and Kenealy W.R. (1992) Production and localization of restrictocin in Aspergillus restrictus. J. Gen. Microbiol. 138, 1429–1435.PubMedCrossRefGoogle Scholar
  12. van Bruggen-Van der Lugt A.W., Kamphuis H.J., De Ruiter G.A., Mischnick P., Van Boom J., and Rombouts F.M. (1992) New structural features of the antigenic extracellular polysaccharides of Penicillium and Aspergillus species revealed with exo-beta-D-galactofuranosidase. J. Bacteriol. 174, 6096–6102.Google Scholar
  13. Buckley H.R., Richardson M.D., Evans E.G.V., and Wheat L.J. (1992) Immunodiagnosis of invasive fungal infection. J. Med. Vet. Mycol. 30 (Suppl 1), 249–260.PubMedCrossRefGoogle Scholar
  14. Burnie J.P., and Matthews R.C. (1991) Heat-shock protein 88 and Aspergillus infection, J. Clin. Microbiol. 29, 2099–2106.PubMedGoogle Scholar
  15. Cohen M.S., Isturiz R.E., Malech H.L., Root R.K., Wilfert C.M., Gutman L., and Buckley R.H. (1981) Fungal infection in chronic granulomatous disease. The importance of the phagocytes in defense against fungi. Amer. J. Med. 71, 59–66.PubMedCrossRefGoogle Scholar
  16. Cohen J. (1991) Clinical manifestations and management of aspergillosis in the compromised patient, in: “Fungal infection in the compromised patient” (Warnock D.W., Richardson M.D. Eds.), 2nd edn, pp. 117–152. John Wiley & Sons, New York.Google Scholar
  17. Cole G.T., and Samson R.A. (1984) The conidia, in: “Mould allergy”, (Al-Doory Y., Domson J.F. Eds.) pp. 66–103. Lea & Febiger, Philadelphia.Google Scholar
  18. Cole P., and Wilson R. (1989) Host microbial interrelationships in respiratory infections. Chest 95, 217–221S.CrossRefGoogle Scholar
  19. Conde F.P., Orlandi R., Canevari S., Mezzanzanica D., Ripamonti M., Munoz S.M., Jorge P., and Colnaghi M.I. (1989) The Aspergillus toxin restriction is a suitable cytotoxic agent for generation of immunoconjugates with monoclonal antibodies directed against human carcinoma cells. Eur. J. Biochem. 178, 795–802.PubMedCrossRefGoogle Scholar
  20. Denning D.W., Ward P.N., Fenelon L.E., and Benbow E.W. (1992) Lack of vessel wall elastolysis in human invasive pulmonary aspergillosis. Infect. Immun. 60, 5153–5156.PubMedGoogle Scholar
  21. Domer J.E., Garner R.E., and Befidi-Mengue R.N. (1989) Mannan as an antigen in cell-mediated immunity (CMI) assays and as a modulator of mannan-specific CMI. Infect. Immun. 57, 693–700.PubMedGoogle Scholar
  22. Eichner R.D., Al Salmi M., Wood P.R., and Müllbacher A. (1986) The effects of gliotoxin upon macrophage function. Int. J. Immunopharmac. 8, 789–797.CrossRefGoogle Scholar
  23. Eichner R.D., Waring P., Geue A.M., Braitwaite A.W., Müllbacher A. (1988) Gliotoxin causes oxidative damage to plasmid and cellular DNA. J. Biol. Chem. 263, 3772–3777.PubMedGoogle Scholar
  24. Fratamico P.M., Long W.K. and Buckley H.R. (1991) Production and characterisation of monoclonal antibodies to a 58-kilodalton antigen of Aspergillus fumigatus. Infect. Immun. 59, 316–322.PubMedGoogle Scholar
  25. Frosco M., Chase T., McMillan J.D. (1992) Purification and properties of the elastase from Aspergillus fumigatus. Infect. Immun. 60, 728–734.PubMedGoogle Scholar
  26. Gumowski P.I., Dunoyer-Geindre S., Goergen F., Latgé J.P., Beffa T., Aragno M., Selldorf P., and Gandolla M. (1992) Evaluation of occupational risk factors for workers in municipal composting facilities. Eur. Resp. J. 5(S15), 406S–407S.Google Scholar
  27. Harvey C., and Longbottom J.L. (1986) Characterization of a major antigenic component of Aspergillus fumigatus. Clin. Exp. Immunol. 65, 206–214.PubMedGoogle Scholar
  28. Harvey C., and Longbottom J.L. (1987) Characterization of a second major antigen Ag 13 (antigen C) of Aspergillus fumigatus and investigation of its immunological reactivity. Clin. Exp. Immunol. 70, 247–254.PubMedGoogle Scholar
  29. Haynes K.A., Latgé J.P., and Rogers T.R. (1990) Detection of Aspergillus antigens associated with invasive infection. J. Clin. Microbiol. 28, 2040–2044.PubMedGoogle Scholar
  30. Hearn V.M. (1992) Antigenicity of Aspergillus species. J. Med. Vet. Mycol. 30, 11–25.PubMedCrossRefGoogle Scholar
  31. Hearn V.M., Moutaouakil M., and Latgé J.P. (1990) Analysis of components of Aspergillus and Neosartorya mycelial preparations by gel electrophoresis and western blotting procedures, in: “Modern concepts in Penicillium and Aspergillus classification” (Samson, R.A. and Pitt, J.I. Eds.), pp. 235. Plenum Press, London, New York.Google Scholar
  32. Hostetter M.K. (1986) Serotypic variations among virulent Pneumococci in deposition and degradation of covalently bound C3b: implications of phagocytosis and antibody production. J. Infect. Dis. 153, 682.PubMedCrossRefGoogle Scholar
  33. Jaton-Ogay K., Suter M., Crameri R., Falchetto R., Fatih A., and Monod M. (1992) Nucleotide sequence of a genomic and a cDNA clone encoding an extracellular alkaline protease of Aspergillus fumigatus. FEMS Microbiol. Lett. 92, 163–168.Google Scholar
  34. Kothary M.H., Chase T. jr, and McMillan J.D. (1984) Correlation of elastase production by some strains of Aspergillus fumigatus with ability to cause pulmonary invasive aspergillosis in mice. Infect. Immun. 43, 320–329.PubMedGoogle Scholar
  35. Kurup V.P. (1989) Murine monoclonal antibodies binding to the specific antigens of Aspergillus fumigatus associated with allergic bronchopulmonary aspergillosis. J. Clin. Lab. Anal. 3, 116–121.PubMedCrossRefGoogle Scholar
  36. Kurup V.P., Greenberger P.A., and Fink J.N. (1989) Antibody response to low-molecular-weight antigens of Aspergillus fumigatus in allergic bronchopulmonary aspergillosis. J. Clin. Microbiol. 27, 1312–1316.PubMedGoogle Scholar
  37. Kurup V.P., John K.V., Resnick A., and Fink J.N. (1986) A partially purified glycoprotein antigen from Aspergillus fumigatus. Int. Archs. Allergy. Appl. Immun. 79, 263–269.CrossRefGoogle Scholar
  38. Kurup V.P., Ramasamy M., Greenberger P.A., and Fink J.N. (1988) Isolation and characterization of a relevant Aspergillus fumigatus antigen with IgG- and IgE-binding activity. Int. Archs Allergy. Appl. Immun. 86, 176–182.CrossRefGoogle Scholar
  39. Lamy B., and Davies J. (1991) Isolation and nucleotide sequence of the Aspergillus restrictus gene coding for the ribonucleic toxin restrictocin and its expression in A. nidulans: the leader sequence protects producing strains from suicide. Nucl. Acids Res. 19, 1001–1006.PubMedCrossRefGoogle Scholar
  40. Lamy B., Moutaouakil M., Latgé J.P., and Davies J. (1991) Secretion of a potential virulence factor, a fungal ribonucleotoxin, during human aspergillosis infections. Mol. Microbiol. 5, 1811–1815.PubMedCrossRefGoogle Scholar
  41. Lamy B., Schindler D., and Davis J. (1991) The Aspergillus ribonucleolytic toxins (ribotoxins), in “Genetically engineered toxins” (Frankel A.E. Ed.) Marcel Dekker Inc., New York.Google Scholar
  42. Larcher G., Bouchara J.P., Annaix V., Symoens F., Chabasse D., and Tronchin G. (1992) Purification and characterization of a fibrinogenolitic serine protease from Aspergillus fumigatus culture filtrate. FEBS Lett. 308, 65–69.PubMedCrossRefGoogle Scholar
  43. Latgé J.P., Debeaupuis J.P., Moutaouakil M., Diaquin M., Sarfati J., Prévost M.C., Wieruszeski J.M., Leroy Y., and Fournet B. (1991a) Galactomannan and the circulating antigens of Aspergillus fumigatus, in “Fungal cell wall and immune response” (Latgé, J. P. and Boucias, D.J. Eds.), pp. 143–151. Springer Verlag, Heidelberg.Google Scholar
  44. Latgé J.P., Moutaouakil M., Debeaupuis J.P., Bouchara J.P., Haynes K., and Prévost M.C. (1991b) The 18-kilodalton antigen secreted by Aspergillus fumigatus. Infect. Immun. 59, 2586–2594.PubMedGoogle Scholar
  45. Levitz S.M. and Diamond R.D (1985) Mechanisms of resistance of Aspergillus fumigatus conidia to killing by neutrophils in vitro. J. Infect. Dis. 152, 33–42.PubMedCrossRefGoogle Scholar
  46. Longbottom J.L. (1986) Antigens and allergens of Aspergillus fumigatus. II: their further identification and partial characterization of a major allergen (Ag 3). J. Allergy Clin. Immunol. 78, 18–24.PubMedCrossRefGoogle Scholar
  47. Longbottom J.L. (1989) Fungal allergens: their characterization with special reference to Aspergillus fumigatus. Adv. Biosci. 74, 43–56.Google Scholar
  48. Mahler P.A., and Kinsella T.J. (1991) Radiation and cytotoxic drug effects on lung natural defence mechanisms, in “Respiratory disease in the immunosuppressed host” (Shelhama J., Pizzo P.A., Parrillo J.E., Masur H. Eds.), pp.30–36. J.B. Lippincott Company, Philadelphia.Google Scholar
  49. Miyaji M., and Nishimura K. (1977) Relationship between proteolytic activity of Aspergillus fumigatus and the fungus’ invasiveness of mouse brain. Mycopathologia 62, 161–166.PubMedCrossRefGoogle Scholar
  50. Monod M., Paris S., Sarfati J., Jaton-Ogay K., Ave P., and Latgé J.P. (1993a) Virulence of alkaline protease-deficient mutants of Aspergillus fumigatus: FEMS Microbiol. Lett. 106, 39–46.PubMedCrossRefGoogle Scholar
  51. Monod M., Togni G., Rahalison L., and Frenk E. (1991) Isolation and characterization of extracellular alkaline protease of Aspergillus fumigatus. J. Med. Microbiol. 35, 23–28.PubMedCrossRefGoogle Scholar
  52. Moser M., Crameri R., Menz G., Schneider T., Dudler T., Virchow C., Gmachl M., Blaser K., and Suter M. (1992) Cloning and expression of recombinant Aspergillus fumigatus allergen I/a (rAsp f 1/a) with IgE binding and type I skin test activity. J. Immunol. 149, 454–460.PubMedGoogle Scholar
  53. Moutaouakil M., Monod M., Prévost M.C., Bouchara J.P., and Latgé J.P. (1993) Identification of the 33-kDa alkaline protease of Aspergillus fumigatus in vitro and in vivo. J. Med. Microbiol. (in press).Google Scholar
  54. Müllbacher A., and Eichner R.D. (1984) Immunosuppression in vitro by a metabolite of a human pathogenic fungus. Proc. Natl Acad. Sci. U.S.A. 81, 3835–3837.PubMedCrossRefGoogle Scholar
  55. Mullins J., Harvey R., and Seaton A. (1976) Sources and incidences of airborne Aspergillus fumigatus. Clin. Allergy 6, 209–217.PubMedCrossRefGoogle Scholar
  56. Munoz A., Castrillo J.L., and Carrasco L. (1985) Modification of membrane permeability during Semliki Forest Virus infection. Virology 146, 203–212.PubMedCrossRefGoogle Scholar
  57. Nelson S., and Summer W.R. (1991) Adverse effects of pharmacologic therapy on pulmonary host defenses, in “Respiratory disease in the immunosuppressed host” (Shelhama J., Pizzo P.A., Parrillo J.E., Masur H. Eds), pp. 15–29. J.B. Lippincott Company, Philadelphia.Google Scholar
  58. Pepys J., and Longbottom J.L. (1971) Antigenic and C-substance activities of related glycopeptides from fungal, parasitic and vegetable sources. Int. Archs Allergy Appl. Immun. 41, 219–221.CrossRefGoogle Scholar
  59. Phillips P., and Radigan G. (1989) Antigenemia in a rabbit model of invasive Aspergillosis. J. Infect. Dis. 159, 1147–1150.PubMedCrossRefGoogle Scholar
  60. Ráper K.B., and Fennell D.I. (1965) Aspergillus fumigatus group, in “The genus Aspergillus”, (Raper K.B. and Fennell, D.I. Eds), pp. 238–268. William & Wilkins, Baltimore.Google Scholar
  61. Reichard U., Büttner S., Eiffert H., Staib F., and Rüchel R. (1990) Purification and characterisation of an extracellular serine proteinase from Aspergillus fumigatus and its detection in tissue. J. Med. Microbiol. 33, 243–251.PubMedCrossRefGoogle Scholar
  62. Reiss E., and Lehmann P.F. (1979) Galactomannan antigenemia in invasive aspergillosis. Infect. Immun. 25, 357–365.PubMedGoogle Scholar
  63. Repentigny L. de, (1989) Serological techniques for diagnosis of fungal infection. Eur. J. Clin. Microbiol. Infect. Dis. 4, 362–375.Google Scholar
  64. Reynolds H.Y. (1991) Pulmonary host defenses, in “Respiratory disease in the immunosuppressed host” (Shelhama J., Pizzo P.A., Parrillo J.E., and Masur H. Eds.), pp. 3–14. J.B. Lippincott Company, Philadelphia.Google Scholar
  65. Robertson M.D., Brown D.M., MacLaren W.M., and Seaton A. (1988) Fungal handling by phagocytic cells from asthmatic patients sensitised and non-sensitised to Aspergillus fumigatus. Thorax 43, 224.CrossRefGoogle Scholar
  66. Robertson M.D., Kerr K.M., Seaton A. (1989) Killing Aspergillus fumigatus spores by human lung macrophages: a paradoxical effect of heat-labile serum component. J. Vet. Med. Mycol. 27, 295–302.CrossRefGoogle Scholar
  67. Robertson M.D., Seaton A., Milne L.J.R., and Raeburn J.A. (1987) Resistance of spores of Aspergillus fumigatus to ingestion by phagocytic cells. Thorax 42, 466–472.PubMedCrossRefGoogle Scholar
  68. Robertson M.D., Seaton A., Milne L.J.R., and Raeburn J.A. (1987) Suppression of host defense by Aspergillus fumigatus. Thorax 42, 19–25.PubMedCrossRefGoogle Scholar
  69. Robertson M.D., Seaton A., Raeburn J.A., and Milne L.J.R. (1987) Inhibition of phagocyte migration and spreading by spore diffusátes of Aspergillus fumigatus. J. Med. Vet. Mycol. 25, 389–396.PubMedCrossRefGoogle Scholar
  70. Rogers T.R., Haynes K.A., and Barnes R.A. (1990) Value of antigen detection in predicting invasive pulmonary aspergillosis. Lancet 336, 1210–1213.PubMedCrossRefGoogle Scholar
  71. Schaffner A. (1989) Experimental basis for the clinical epidemiology of fungal infections. A review. Mycoses 32, 499–515.PubMedCrossRefGoogle Scholar
  72. Schönheyder H., Jensen T., Hoiby N., and Koch C. (1988) Clinical and serological survey of pulmonary aspergillosis in patients with cystic fibrosis. Int. Archs Allergy Appl. Immun. 85, 472–477.CrossRefGoogle Scholar
  73. Seaton A., Seaton D., and Leitch A.G. (1989) “Crofton and Douglas’s respiratory diseases”, pp. 1215. Blackwell Scientific Publ., Oxford.Google Scholar
  74. Sciglemurandi F., Krivobok S., Steiman R., and Marzin D. (1990) Production, mutagenicity, and immunotoxicity of gliotoxin. J. Agric. Fd Chem. 38, 1854–1856.CrossRefGoogle Scholar
  75. Steinfort C., Wilson R., Mitchell T., Feldman C., Rutman A., Todd H., Sykes D., Walker J., Saunders K., Andrew P.W., Bournois G.J., and Cole P. (1989) Effect of Streptococcus pneumoniae on human respiratory epithelium in vitro. Infect. Immun. 57, 2006–2013.PubMedGoogle Scholar
  76. Sturtevant J., and Latgé J.P. (1992a) Interactions between conidia of Aspergillus fumigatus and human complement component C3. Infect. Immun. 60, 1913–1918.PubMedGoogle Scholar
  77. Sturtevant J., and Latgé J.P. (1992b) Participation of complement in the phagocytosis of the conidia of Aspergillus fiimigatus by human polymorphonuclear cells. J. Infect. Dis. 166, 580–586.PubMedCrossRefGoogle Scholar
  78. Stynen D., Sarfati J., Goris A., Prévost M.C., Lesourd M., Kamphuis H., Darras V., and Latgé J.P. (1992) Rat monoclonal antibodies against Aspergillus galactomannan. Infect. Immun. 60, 2237–2245.PubMedGoogle Scholar
  79. Tang C.M., Cohen J., and Holden D.W. (1992) An Aspergillus fiimigatus alkaline protease mutant constructed by gene disruption is deficient in extracellular elastase activity. Mol. Microbiol. 6, 1663–1671.PubMedCrossRefGoogle Scholar
  80. Taylor M.L., and Longbottom J.L. (1988) Partial characterization of rapidly released antigenic/allergenic component (Ag5) of Aspergillus fiimigatus. J. Allergy Clin. Immunol. 81, 548–557.PubMedCrossRefGoogle Scholar
  81. Turner W.B., and Aldridge D.C. (1983) “Fungal metabolites”, II, pp. 631. Academic Press, London.Google Scholar
  82. Unkefer C.J., and Gander J.E. (1979) The 5–0-beta-D-galactofuranosyl-containingglycopeptide from Penicillium charlesii. Carbon-13 nuclear magnetic resonance studies. J. Biol. Chem. 254, 12131–12135.PubMedGoogle Scholar
  83. Unkefer C.J., and Gander J.E. (1990) The 5–0-beta-D-galactofuranosyl-containing peptido-phospho-galactomannan of Penicillium charlesii. Characterization of the mannan by 13-C NMR spectroscopy. J. Biol. Chem. 265, 685–689.PubMedGoogle Scholar
  84. Wagner G.E. (1984) Bronchopulmonary aspergillosis and aspergilloma, in “Mould allergy” (Al-Doory Y., Domson J.F. Eds.) pp. 202–216. Lea & Febiger, Philadelphia.Google Scholar
  85. Waldorf A.R. (1989) Pulmonary defense mechanisms against opportunistic fungal pathogens, in: “Immunology of fungal diseases” Immunol series 47 (Waldorf A.R. Eds.) pp. 243–270. Marcel Dekker, New York.Google Scholar
  86. Waring P., Eichner R.D., Müllbacher A., and Sjaarda A. (1988) Gliotoxin induces apoptosis in macrophages unrelated to its antiphagocytic properties. J. Biol. Chem. 263, 18493–9.PubMedGoogle Scholar
  87. Washburn R.G., DeHart D.J., Agwu D.E., Bryant-Varela B.J., and Julian N.C. (1990) Aspergillus fiimigatus complement inhibitor: production, characterization, and purification by hydrophobic interaction and thin layer chromatography. Infect. Immun. 58, 3508–3515.PubMedGoogle Scholar
  88. Washburn R.G., Hammer C.H., and Bennett J.E. (1986) Inhibition of complement by culture supernatants of Aspergillus fiimigatus. J. Infect. Dis. 154, 944–951.PubMedCrossRefGoogle Scholar
  89. Wawrzynczak E.J., Henry R.V., Cumber A.J., Parnell G.D., Derbyshire E.J., and Ulbrich N. (1991) Biochemical, cytotoxic and pharmacokinetic properties of an immunotoxin composed of a mouse monoclonal antibody Fib75 and the ribosome-inactivating protein alpha-sarcin from Aspergillus giganteus. Eur. J. Biochem. 196, 203–209.PubMedCrossRefGoogle Scholar
  90. Wilson R., Read R., Thomas M., Rutman A., Harison K., Lund V., Cookson B., Goldman W., Lambert H., and Cole P. (1991) Effects of Bordetella pertussis infection on human respiratory epithelium in vivo and in vitro. Infect. Immun. 59, 337–345.PubMedGoogle Scholar
  91. Yang R., and Kenealy W.R. (1992) Effects of amino-terminal extensions and specific mutations on the activity of restrictocin. J. Biol. Chem. 267, 16801–16805.PubMedGoogle Scholar
  92. Yu B., Niki Y., and Armstrong D. (1990) Use of immunoblotting to detect Aspergillus fiimigatus antigen in sera and urines of rats with experimental invasive aspergillosis. J. Clin. Microbiol. 28, 1575–1579.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • J. P. Latgé
    • 1
  • S. Paris
    • 1
  • J. Sarfati
    • 1
  • J. P. Debeaupuis
    • 1
  • M. Monod
    • 2
  1. 1.MycologieInstitut PasteurParisFrance
  2. 2.DermatologieCHUVLausanneSwitzerland

Personalised recommendations